IndulgeRx wins clean WIPO patent sweep for IRX FOODSCORE

IndulgeRx Brands Inc. says WIPO has published all three of its PCT patent applications for the IRX FOODSCORE platform, each backed by an International Search Report that found no blocking prior art. The company says the result strengthens its IP position as it moves toward seed and Series A fundraising and partnership talks.

Why it matters: - IndulgeRx says the WIPO publication and search results provide independent support for its patent position around IRX FOODSCORE®, an AI-driven nutrition platform. - The company says the milestone reduces IP risk for investors, strategic acquirers and partners considering the business. - IndulgeRx also says the patent position supports twelve monetizable use cases across consumer apps, CPG licensing, retail, payers and providers, pharmacists, sports performance, researchers and government agencies.

What happened: - IndulgeRx Brands Inc. announced that WIPO published all three of its Patent Cooperation Treaty applications on July 23, 2026. - The applications cover IRX FOODSCORE® as a system, software and business method. - Each application received an “all-A” International Search Report from the U.S. International Searching Authority. - The published application numbers are WO2026156106 A1 for IRX FS SOFTWARE, WO2026156110 A1 for IRX FS METHOD and WO2026156104 A1 for IRX FS SYSTEM. - The company said the WIPO records are publicly available through WIPO PATENTSCOPE.

The details: - IndulgeRx said every claim in the three applications was found to be novel, inventive and industrially applicable. - The company said the search reports included zero “X” citations and zero “Y” citations, with every reference graded “A.” - IndulgeRx said the written opinions affirmed novelty, inventive step and industrial applicability for claims 1 through 15. - The patent examiner said combining prior art to reject the claims “would be impermissible hindsight,” according to the company’s release. - The examiner also said any such combination “would not provide any advantages over the present application, or would require a complexity beyond the level of ordinary skill,” the company said. - IndulgeRx said the filings share a locked priority date of January 16, 2025. - Patent counsel said one filing required a minor procedural claim-grouping clarification that did not affect the “A” grades or the novelty findings. - IRX FOODSCORE® analyzes health history, age, gender, medications and goals against ingredients, additives, preservatives and preparation methods. - The platform generates two outputs: a Relevant Nutrition Score and a Relevant Risk Score.

Between the lines: - A clean International Search Report does not guarantee patent grants, but it can signal stronger claims and a more defensible IP story. - IndulgeRx is framing the result as proof that a smaller self-funded company can clear the same global review process faced by much larger technology firms. - The company is also using the result to sharpen its pitch ahead of seed and Series A discussions. - The release positions IRX FOODSCORE® less as a single feature and more as a platform with multiple commercial paths.

What’s next: - IndulgeRx says the WIPO publication now makes the applications part of the public record. - The company is expected to continue investor and partnership talks while it builds around the published patent portfolio. - Further development will likely center on commercializing IRX FOODSCORE® across the use cases highlighted in the release.

The bottom line: - IndulgeRx turned a patent process milestone into a broader product and fundraising signal, and the company now has public WIPO records to back that claim.